HAIN
The Hain Celestial Group, Inc.1.1100
-0.0600-5.13%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
100.53MP/E (TTM)
-Basic EPS (TTM)
-5.90Dividend Yield
0%Recent Filings
8-K
8-K
10-K
FY2025 results
Hain Celestial's FY2025 net sales fell 10.2% y/y to $1.56B, with organic sales down 6.5% amid volume/mix weakness and divestitures, though Q4 showed modest sequential stabilization in North America snacks via pricing actions. Gross margins compressed to 21.4% from 21.9%, pressured by inflation and trade spend, yet productivity gains lifted Adjusted EBITDA to $113.8M despite $428.9M goodwill impairments tied to market cap declines and strategic reviews. North America drove the downturn with 15.8% sales drop, while International held steadier at -1.4%; Q4 momentum hinged on UK soups offsetting beverage softness. Liquidity stood firm with $54.4M cash and $246.7M revolver availability, no buybacks executed under the $173.5M program. No formal FY2026 guidance issued amid ongoing portfolio review. Intense competition risks eroding quarterly gains if consumer shifts persist.
8-K
Hain's 2025 earnings slump
The Hain Celestial Group reported fiscal 2025 results on September 15, 2025, with net sales dropping 10% to $1.56B amid 7% organic declines from volume weakness in snacks and meal prep, while gross margins slipped to 21.4%. Heavy $496M impairment charges fueled a $531M net loss, yet adjusted EBITDA held at $114M and debt fell to $705M. Management is slashing costs and streamlining operations for cash flow gains. Leverage covenant now caps at 5.50x.
8-K
CEO Transition and Q3 Miss
The Hain Celestial Group announced on May 7, 2025, that CEO Wendy Davidson departed effective May 6, with board member Alison Lewis stepping in as interim CEO the next day, backed by a $100,000 monthly salary and $900,000 RSU grant. Amid Q3 results showing net sales down 11% to $390 million and a $135 million net loss driven by $133 million impairments, the board launched a strategic portfolio review with Goldman Sachs to boost shareholder value. North America sales plunged 17%, yet international grew organically 0.5%. Leadership shakeup signals urgency.
CAG
ConAgra Brands, Inc.
17.74-0.20
HCWC
Healthy Choice Wellness Corp.
0.27-0.00
HLF
Herbalife Ltd.
14.45-0.45
HRL
Hormel Foods Corporation
23.66-0.34
KHC
The Kraft Heinz Company
24.68+0.18
LWAY
Lifeway Foods, Inc.
23.78+0.52
NATR
Nature's Sunshine Products, Inc
22.38-0.85
OTLY
Oatly Group AB
11.22+0.13
SMPL
The Simply Good Foods Company
19.11-0.19
USNA
USANA Health Sciences, Inc.
20.33+0.01